University of Exeter Finds Diabetes Genes
Analysis based on 8 articles · First reported Apr 09, 2026 · Last updated Apr 13, 2026
This medical breakthrough by the University of Exeter could lead to new treatments for neonatal diabetes and potentially type 1 diabetes, positively impacting pharmaceutical and biotechnology companies involved in diabetes research and drug development. While not directly affecting stock prices immediately, it signals future opportunities for innovation in the healthcare sector.
Scientists at the University of Exeter, supported by the United Kingdom — National Institute for Health and Care Research, have discovered new genetic causes for neonatal diabetes in babies. The research, led by Elisa De Franco and co-authored by James Russ-Silsby and Matthew Johnson, found that DNA changes in non-coding genes RNU4ATAC and RNU6ATAC are responsible for autoimmune neonatal diabetes in 19 children. This finding is significant because it highlights the importance of non-protein coding genes, which have been historically overlooked, and could lead to new treatments and drug targets for both rare neonatal diabetes and more common type 1 diabetes. The study was published in the American Journal of Human Genetics and will be presented at the European Society of Human Genetics conference.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard